About Molecular Assemblies, Inc.
We are Molecular Assemblies, Inc., a life sciences company founded in San Diego in 2013. We are now part of TriLink BioTechnologies.
Our patented Fully Enzymatic Synthesis (FES™) technology uses natural enzymatic processes to synthesize DNA. This method allows us to produce long, high-quality, sequence-specific DNA reliably, affordably, and sustainably.
FES™ technology has a 99.9% step-wise incorporation efficiency, creating highly accurate oligonucleotides up to 400 bases. This process eliminates the need for post-synthesis purification and speeds up the delivery of pure DNA. FES™ can also synthesize sequences traditionally considered “difficult,” such as those with high or low GC content, long homopolymer stretches, and repetitive elements. We achieve this by operating at optimized temperatures (up to 70C) and a neutral pH environment.
Our technology applies to various industries, including industrial synthetic biology, precision medicine, nanomachines, bio-based electronics, clinical medicine, pharmaceuticals, agriculture, food, therapeutics, vaccines, immunotherapy, and nanotechnology. We focus on areas like DNA, CRISPR, CAR-T Therapy, Diagnostics, AgBio, SynBio, Synthetic Biology, Gene Editing, Genetic Medicines, DNA Data Storage, and Cell Therapy.
Frequently Asked Questions
Molecular Assemblies utilizes its patented Fully Enzymatic Synthesis (FES™) technology, an enzyme-based process that synthesizes DNA similarly to how nature makes DNA.
The Fully Enzymatic Synthesis (FES™) technology produces long DNA (up to 400 bases) with 99.9% step-wise incorporation efficiency, resulting in high purity without the need for post-synthesis purification. It also accelerates delivery times and can synthesize ‘difficult’ sequences more easily.
The technology impacts industrial synthetic biology, precision medicine, nanomachines, bio-based electronics, clinical medicine, pharmaceuticals, agriculture, food, therapeutics/vaccines, immunotherapy, and nanotechnology, among others.
Molecular Assemblies, Inc. is now part of TriLink BioTechnologies.
Molecular Assemblies, Inc. was founded in 2013.
Molecular Assemblies, Inc. is active in the Dna, Crispr, Vaccines, Car-t Therapy, Dna Synthesis, Enzymatic Dna Synthesis, Diagnostics, Agbio, Synbio, Synthetic Biology, Gene Editin, Genetic Medicines, Dna Data Storage, Cell Therapy, and Cell Therapies markets.
Molecular Assemblies, Inc. has 51-200 employees.
Molecular Assemblies, Inc. hires globally with a remote-first approach, allowing employees to work from anywhere.
Molecular Assemblies, Inc. is not actively hiring at the moment. Check back later for new opportunities.
Yes, Molecular Assemblies, Inc. is a remote-first company.
Molecular Assemblies, Inc.'s website is www.molecularassemblies.com .
You can find Molecular Assemblies, Inc. on LinkedIn .
Remote companies like Molecular Assemblies, Inc.
Find your next opportunity with companies that specialize in Dna, Crispr, Vaccines, and Car-t Therapy. Explore remote-first companies like Molecular Assemblies, Inc. that prioritize flexible work and home-office freedom.
GenScript
Services and products for biotech and healthcare research, focusing on gene, peptide, protein, and antibody solutions.
Luminary Group
Provides executive search and leadership advisory services to Life Sciences and Pharmaceutical sectors.
Project: Career Search
Rev. 2026.2
[ Remote Jobs ]
Direct Access
We source jobs directly from 21,000+ company career pages. No intermediaries.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.